Integer Holdings Corporation reports news as a medical device contract development and manufacturing organization serving cardio and vascular, neuromodulation, and cardiac rhythm management markets. Company updates commonly cover sales trends, organic growth, product-line performance, adjusted earnings measures, debt and leverage, and outlook commentary tied to customer programs and new product activity.
Integer news also includes governance and capital-allocation developments, including board composition, shareholder engagement, share repurchase authorization, investor conference participation, and broader strategy updates. The company’s public identity includes the Greatbatch Medical and Lake Region Medical brands and engineering and manufacturing work for medical device customers.
Integer Holdings (NYSE: ITGR) reported third-quarter sales of $449.661 million, down 3.9% from the comparable 2025 quarter, alongside lower earnings. For the three months ended October 2, 2026, organic sales fell 2.2%. GAAP income from continuing operations declined 62.3% to $14.978 million, and diluted earnings per share fell to $0.43 from $1.11. Adjusted earnings per share declined 25.1% to $1.34.
Cardio & Vascular sales fell 5.1%, while Cardiac Rhythm Management & Neuromodulation sales rose 3.9%. Total debt reached $1.219 billion, with leverage at 3.3 times adjusted EBITDA. Stockholders approved the pending acquisition by an affiliate of KKR-managed funds. Integer anticipates closing by year-end 2026, subject to remaining conditions, including required regulatory approvals. The company is not providing a financial outlook or hosting an earnings call because of the pending transaction.
Integer Holdings (NYSE: ITGR) stockholders approved the merger agreement for Armstrong Parent’s proposed acquisition of the company at a special meeting. Approximately 99.95% of shares voted on the merger proposal supported it, representing approximately 76.66% of total outstanding common shares as of September 8, 2026. The agreement is dated August 2, 2026.
Stockholders also approved, by a majority of votes cast, a non-binding advisory proposal covering transaction-related compensation that will or may become payable to named executive officers. The companies anticipate closing by the end of 2026, subject to satisfaction or waiver of closing conditions, including receipt of required regulatory approvals. Integer will report the full voting results in a Form 8-K filed with the SEC.
Integer Holdings (ITGR) opened a conversion window for its 2.125% Convertible Senior Notes due 2028, beginning October 1, 2026.
Holders may convert through the close of business on December 31, 2026. The conversion rate is 11.4681 shares per $1,000 principal amount, equivalent to approximately $87.20 per share. Settlement is in cash up to principal; Integer may settle any excess in cash, common shares or both.
The notes became convertible because the stock's last reported sale price exceeded 130% of the applicable conversion price on at least 20 trading days within the 30 consecutive trading days ending on the last trading day of the quarter ended September 30, 2026. Future conversion eligibility will follow the indenture's terms.
Integer Holdings (NYSE: ITGR) received early termination of the antitrust waiting period for its pending acquisition by a KKR affiliate. Ending the Hart-Scott-Rodino waiting period satisfies one condition for completing the transaction. Under the definitive merger agreement dated August 2, 2026, an affiliate of investment funds managed by KKR will acquire all outstanding Integer shares for $127 per share in cash. The transaction represents approximately $5.7 billion in enterprise value.
Completion remains subject to Integer stockholder approval and satisfaction or waiver of other regulatory approvals and customary closing conditions. Integer continues to expect closing by the end of 2026, subject to those conditions. A virtual special stockholder meeting on October 21, 2026 will vote on the merger agreement and related proposals. The board unanimously recommends voting in favor.
Integer Holdings (NYSE: ITGR) reported second quarter 2026 sales of $464 million, down 2.6% year over year, with organic sales lower by 1.5%. GAAP operating income from continuing operations was $34.5 million, down 41.8%, and GAAP income from continuing operations was $23.6 million, down 36.2%.
Non-GAAP adjusted operating income was $73.0 million, down 10.2%, while adjusted EBITDA was $94.9 million, down 4.1%. Adjusted net income was $54.7 million, essentially flat, and adjusted EPS increased 3.2% to $1.60. Total debt rose to $1.238 billion, resulting in a leverage ratio of 3.2x adjusted EBITDA.
According to Integer, an affiliate of KKR will acquire all outstanding shares in an all‑cash transaction valued at $5.7 billion enterprise value, with shareholders to receive $127 per share. In light of the pending transaction, Integer withdrew its financial outlook and canceled its scheduled earnings call.
Integer (NYSE: ITGR) agreed to be acquired by an affiliate of investment funds managed by KKR (NYSE: KKR) in an all-cash transaction valuing Integer at an enterprise value of approximately $5.7 billion. Integer stockholders are to receive $127 per share in cash, a premium of about 51.8% to the April 29, 2026 closing price and 28.8% to the 30-day VWAP as of July 31, 2026.
The Integer Board unanimously approved the merger, following a strategic review begun April 30, 2026, and recommends stockholders vote for it. Closing is expected by year-end, subject to stockholder and regulatory approvals, and is not subject to a financing contingency. KKR will fund the deal with equity from its managed funds and committed debt. After closing, Integer will become a private company and its shares will be delisted from the NYSE. Integer also withdrew its financial outlook and cancelled its August 6, 2026 earnings call due to the pending transaction.
Integer (NYSE:ITGR) will host a webcast conference call to discuss Q2 2026 financial results and business highlights on Thursday, Aug. 6, 2026 at 8 a.m. CT (9 a.m. ET).
The company will release its second quarter 2026 results earlier that day and provide live and replay access via phone and its investor relations website.
Integer (NYSE: ITGR) announced it will participate in the Truist Securities 2026 MedTech Conference on June 16, 2026. Executive leaders will join a fireside chat at 10:40 a.m. ET, with a live webcast and replay available on the company’s investor relations website.
Integer (NYSE: ITGR) announced that its Board has initiated a strategic review to evaluate a full range of options, including a sale, merger, or strategic business combination versus continued standalone execution.
The Board cited strong interest received, appointed Goldman Sachs & Co. LLC as financial advisor and Davis Polk & Wardwell LLP as legal advisor, and set no timeline or assurance that a transaction will occur.
Integer Holdings (NYSE:ITGR) reported Q1 2026 results: sales $440 million (+0.5%), organic sales +1.3%, GAAP income from continuing operations $17 million (+173%), and adjusted operating income $61 million (down 14%).
The Board initiated a strategic review to maximize stockholder value; 2026 outlook provided with GAAP and non-GAAP ranges and leverage guidance of 2.5x–3.5x.